Antepartum problems Flashcards

1
Q

gestational diabetes

A

any degree of glucose inteolerance with onset or recognition during pregnancy; identified during 2nd or 3rd trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diabetes goal

A

optimal outcome is strict maternal glucose control before conception and throughout the pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Insulin 1st tri

A

less insulin needed; risk hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

insulin 2nd tri

A

gradually increase; need about back to baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

insuline 3 tri

A

insulin dose above baseline (2-4x)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hormones that cause insuline resistance

A

HPL, prolactin, estrogen, progesterone, cortisol, insulinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

non-diabetics

A

pancrease compensates for insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

maternal complications with preexisting diabetes

A

miscarriage- 1st trimester
macrosomnia
hydramnios
ketoacidosis
hyperglycemia
hypoglycemia
preeclampsia
infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

fetal and neonatal risk preexisting diabetes

A

sudden and unexplained still birth
congenital malformations
birth injuries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

prenatal evaluation

A

Laboratory test (pregestational): renal function, thyroid function, glycosylated hemoglobin A (HgbA1C)
Urine testing for UTI, glucose, protein at PN visits
Monitoring blood glucose levels & logging
Maintain FBS 65-105; 2 hr PP <120
Determination of birth date and mode of birth
Complications requiring hospitalization
Fetal surveillance/consider effects on fetus:
Additional ultrasound evaluations; measurement of MSAFP; echo; DFMC @ 28 wks; NST @ 32 wks
↑glucose in mom→fetal insulin production (structure similar to growth hormone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

preexisting dm- action

A

nutrition counseling, insulin (3rd tri especially), diet and exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GDM risk

A

fam hx
obesity
HTN
glucosuria
maternal age >25
more than 1/2 without risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

maternal GDM risk

A

preeclampsia
cesarean birth
dev type 2 DM later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

neonatal GDM risk

A

macrosomia
birht injuries
electrolyte imbalance
hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

OGTT

A

routine screening between 24 and 28 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Intrapartume care GDM

A

monitor closely
complications: dehydration, hypo/hyperglycemia
may require a cesarean birth

17
Q

Postpartum care GDM

A

Insulin requirements decrease substantially (as little as 1/2 to ⅓ the pregnancy dose): the placenta was the major source of insulin resistance
Newborn: glucose source gone after delivery🡪hypoglycemia within 1 hour
Risk for preeclampsia/eclampsia, hemorrhage (overdistention &/or overstimulation-oxytocin), infection
Encourage breastfeeding (antidiabetogenic effect on child & decreased risk of childhood obesity if breastfed for at least 6 mos)
Contraception

18
Q

HTN types

A

chronic essential
gestational
preeclampsia

19
Q

chronic HTN

A

Present before the pregnancy or diagnosed before week 20 of gestation or persists beyond the PP period

20
Q

gestational HTN

A

SBP >140/90 on 2 occasions at least 4 hours apart, with previously normal blood pressure, after the 20th week of pregnancy
Resolves PP but may take 6-12 months

21
Q

Preeclampsia→eclampsia

A

Pregnancy-specific condition
Hypertension with proteinuria develops after 20 weeks of gestation in previously normotensive client; may develop PP
A vasospastic systemic disorder categorized as mild or severe
Decreased placental perfusion & hypoxia
Eclampsia: onset of seizure activity or coma in client with PreE with no history of seizure pathology

22
Q

Chronic hypertension with superimposed preeclampsia

A

Women with chronic hypertension may acquire preeclampsia or eclampsia

23
Q

PreE pathophysicology

A

Progresses along a continuum from mild to severe
Caused by disruptions in placental perfusion
Placental ischemia stimulates release of a substance toxic to endothelial cells
Poor tissue perfusion in all organ systems; increased peripheral resistance & BP
Reduced kidney perfusion

24
Q

PreE etiology

A

Signs and symptoms develop only during pregnancy and disappear after birth
Associated high-risk factors: history of preE, multifetal pregnancy, chronic hypertension, diabetes, renal disease, autoimmune disease
Associated moderate risk factors: family history, obesity, maternal age 35 & older, Black race, low SES, more than 10-year pregnancy interval

25
Q

Identify and Prevent PreE

A

Assess:
Edema
Deep tendon reflexes
Clonus
RUQ/epigastric pain
Headaches (frontal)
Visual disturbance

26
Q

diagnostic Cue

A

proteinuria (>0.3)

27
Q

PreE effects on fetus

A

fetal growth restriction
decreased amniotic fluid volume
abnormal fetal oxygenation
LBW
preterm birht

28
Q

preE sever features

A

BP 160/110 X 2, at least 4h apart or higher
Massive proteinuria
Platelet count <100,000
Abnormal liver function
Progressive renal insufficiency
Pulmonary edema
Cerebral/visual disturbance

29
Q

HELLP syndrome

A

Laboratory diagnostic variant of severe preeclampsia
involves hepatic dysfunction, characterized by:
Hemolysis (H)
Elevated liver enzymes (EL)
Low platelets (LP)
Usually develops in antepartum period
Malaise
Influenza-like symptoms
Epigastric/RUQ abdominal pain
Symptoms worsen at night, better during daytime
Can progress rapidly

30
Q

HELLP increase risk for

A

pulmonary edema
renal failure
liver hemorrhage or failure
disseminated intravascular coagulation
placental abruption
acute respiratory distress syndrome
sepsis
stroke
fetal and maternal death

31
Q

actions for gestational HTN and PreE without sever features

A

Maternal and fetal assessment: BP, urine, labs, S&S, DFMC, NST, fetal growth, amniotic fluid volume
Activity modification
See Patient Teaching

32
Q

Preeclampsia with severe features

A

Greater risk for pregnancy complications→hospitalize
Magnesium sulfate to prevent eclampsia (Box 12.3) (MED SHEET)
Monitor BP, reflexes, urine output, cerebral status, presence of epigastric pain, tenderness, labor or vaginal bleeding
Low stim environment/seizure precautions
Antihypertensive therapy, if necessary (labetalol, nifedipine)
Maternal eval: serial BP, symptom assessment, lab evaluation
Fetal monitoring: ultrasound (fetal growth, fluid volume), NST/BPP
Corticosteroids (betamethasone/dexamethasone) for fetal lung development up to 34 wks; deliver at 34 wks or greater

33
Q

PreE with seve features actions

A

Intrapartum care
Early identification of abnormal FHR & prevention of maternal complications
Assess for signs of placental abruption (vaginal bleeding, tense tender uterus, uterine tachysystole)
Assess CNS, CV, pulmonary, hepatic, renal
Seizure precautions
Future health care
Increased risk for severe preeclampsia with future pregnancy, development of chronic hypertension and CV disease later in life–educate on lifestyle changes

34
Q

Eclampsi

A

Prevention! – Prenatal care for assessment and early interventions
Usually preceded by premonitory S&S: persistent headache, blurred vision, severe epigastric or RUQ pain, altered mental status
Immediate care: ensure patent airway and patient safety
How would you respond to a patient having a seizure???

35
Q

associated with chronic HTN

A

placental abruption
superimposed preeclampsia
increase perinatal mortality
fetal effect
- growth restriction
- preterm birth

36
Q

Anithypertensive meds

A

labatalol- safe for breastfeeding